| ASSET | YEAR | % RETURN |
|---|---|---|
BridgeBio Pharma (BBIO) | 2019 | 14.51% |
BridgeBio Pharma (BBIO) | 2020 | 102.19% |
BridgeBio Pharma (BBIO) | 2021 | -76.55% |
BridgeBio Pharma (BBIO) | 2022 | -55.56% |
BridgeBio Pharma (BBIO) | 2023 | 418.89% |
BridgeBio Pharma (BBIO) | 2024 | -31% |
BridgeBio Pharma (BBIO) | 2025 | 38.97% |
